CLINICAL SIGNIFICANCE OF DIABETIC POLYNEUROPATHY AND FOOT COMPLICATIONS IN TYPE 2 DIABETES MELLITUS
Keywords:
type 2 diabetes mellitus, diabetic polyneuropathy, peripheral neuropathy, diabetic foot, hyperglycemia, monofilament test, amputation, foot ulcer.Abstract
This article analyzes diabetic polyneuropathy developing in the context of type 2 diabetes mellitus, its clinical course, the importance of early detection, and severe complications such as diabetic foot ulcers, risk of amputation, and autonomic neuropathy. Long-term hyperglycemia in diabetes leads to microvascular injury, impaired nerve fiber function, and loss of protective sensation. Since diabetic peripheral neuropathy may often progress without obvious symptoms, regular screening, including the 10 g monofilament test, assessment of vibration sensation, and evaluation of temperature sensitivity, is of great clinical importance. The article also highlights the role of glycemic control, blood pressure management, lipid regulation, body weight optimization, and proper foot care in reducing the risk of diabetes-related complications.
References
1.American Diabetes Association Professional Practice Committee for Diabetes. (2026). Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes—2026. Diabetes Care, 49(Supplement 1), S261–S276.
2.Marso, S. P., et al. (2016). Liraglutide and cardiovascular outcomes in type 2 diabetes. New England Journal of Medicine.
3.Neal, B., et al. (2017). Canagliflozin and cardiovascular and renal events in type 2 diabetes. NEJM.
4.ERGASHEVA, G. T. (2024). OBESITY AND OVARIAN INSUFFICIENCY. Valeology: International Journal of Medical Anthropology and Bioethics, 2(09), 106-111.
5.Ergasheva, G. T. (2024). Modern Methods in the Diagnosis of Autoimmune Thyroiditis. American Journal of Bioscience and Clinical Integrity, 1(10), 43-50.
6.Tokhirovna, E. G. (2024). COEXISTENCE OF CARDIOVASCULAR DISEASES IN PATIENTS WITH TYPE 2 DIABETES. TADQIQOTLAR. UZ, 40(3), 55-62.
7.Toxirovna, E. G. (2024). DETERMINATION AND STUDY OF GLYCEMIA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WITH COMORBID DISEASES. TADQIQOTLAR. UZ, 40(3), 71-77.
8.Toxirovna, E. G. (2024). XOMILADORLIKDA QANDLI DIABET KELTIRIB CHIQARUVCHI XAVF OMILLARINI ERTA ANIQLASH USULLARI. TADQIQOTLAR. UZ, 40(3), 63-70.
9.Toxirovna, E. G. (2024). QANDLI DIABET 2-TIP VA KOMORBID KASALLIKLARI BO’LGAN BEMORLARDA GLIKEMIK NAZORAT. TADQIQOTLAR. UZ, 40(3), 48-54.
10.Tokhirovna, E. G. (2024). MECHANISM OF ACTION OF METFORMIN (BIGUANIDE) IN TYPE 2 DIABETES. JOURNAL OF HEALTHCARE AND LIFE-SCIENCE RESEARCH, 3(5), 210-216.
11.Tokhirovna, E. G. (2024). THE ROLE OF METFORMIN (GLIFORMIN) IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS. EUROPEAN JOURNAL OF MODERN MEDICINE AND PRACTICE, 4(4), 171-177.
12.Эргашева, Г. Т. (2024). Эффект Применения Бигуанида При Сахарным Диабетом 2 Типа И Covid-19. Research Journal of Trauma and Disability Studies, 3(3), 55-61.
13.Toxirovna, E. G. (2024). QANDLI DIABET 2 TUR VA YURAK QON TOMIR KASALLIKLARINING BEMOLARDA BIRGALIKDA KECHISHI. ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ, 38(7), 202-209.
14.Эргашева, Г. Т. (2024). СОСУЩЕСТВОВАНИЕ ДИАБЕТА 2 ТИПА И СЕРДЕЧНО-СОСУДИСТЫХ ЗАБОЛЕВАНИЙ У ПАЦИЕНТОВ. ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ, 38(7), 219-226.




United Kingdom
Germany
France
Uzbekistan
Türkiye
Kazakhstan
Kyrgyzstan
Turkmenistan
Azerbaijan
India
Republic of Korea
Japan
United States of America
Kosovo
Italy
Spain
Poland
Netherlands
Belgium
Sweden
Norway
Finland
Denmark
Switzerland
Austria
Czech Republic
Hungary
Romania
Bulgaria
Greece
Portugal